137934-48-6

Upstream product

• 124-63-0 methanesulfonyl chloride 
• 133995-30-9 (2S,4S)-2-hydroxymethyl-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine 
• 126408-14-8 methyl (2S,4R)-N-(allyloxycarbonyl)-4-hydroxypyrrolidine-2-carboxylate 
• 625388-36-5 (2S,4S)-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine-2-carboxylic acid methyl ester 
• 126438-17-3 (2S,4R)-1-allyloxycarbonyl-4-methanesulfonyloxy-2-methoxycarbonylpyrrolidine 
• 3695-77-0 triphenylmethanethiol 

Downstream Products

• 156442-16-9 (2S,4S)-2-cyanomethyl-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine 
• 675836-73-4 (2R,4S)-2-[5-(2,3-Dihydroxy-propylcarbamoyl)-[1,2,4]oxadiazol-3-ylmethyl]-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 675836-72-3 (2R,4S)-2-[5-(3-Hydroxy-propylcarbamoyl)-[1,2,4]oxadiazol-3-ylmethyl]-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 675836-74-5 (2R,4S)-2-[5-(2-Amino-ethylcarbamoyl)-[1,2,4]oxadiazol-3-ylmethyl]-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 675836-71-2 (2R,4S)-2-[5-(2-Hydroxy-ethylcarbamoyl)-[1,2,4]oxadiazol-3-ylmethyl]-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 675836-70-1 (2R,4S)-2-(5-Dimethylcarbamoyl-[1,2,4]oxadiazol-3-ylmethyl)-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 675836-69-8 (2R,4S)-2-(5-Methylcarbamoyl-[1,2,4]oxadiazol-3-ylmethyl)-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 675836-65-4 (2S,4S)-2-[(5-ethoxycarbonyl)-1,2,4-oxadiazol-3-ylmethyl]-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine 
• 675836-68-7 (2S,4S)-2-[(5-carbamoyl)-1,2,4-oxadiazol-3-ylmethyl]-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine 
• 675836-66-5 (2S,4S)-2-[(5-hydroxymethyl)-1,2,4-oxadiazol-3-ylmethyl]-4-tritylthio-1-(allyloxycarbonyl)pyrrolidine 
• 625388-37-6 (2R,4S)-2-(N-Hydroxycarbamimidoylmethyl)-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 625388-57-0 (2R,4S)-2-{2-[(Z)-Hydroxyimino]-2-[(4-hydroxy-piperidine-1-carbonyl)-amino]-ethyl}-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 625388-55-8 (2R,4S)-2-{2-[(Z)-Hydroxyimino]-2-[(piperazine-1-carbonyl)-amino]-ethyl}-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 
• 625388-54-7 (2R,4S)-2-{2-[(Z)-Hydroxyimino]-2-[(thiomorpholine-4-carbonyl)-amino]-ethyl}-4-tritylsulfanyl-pyrrolidine-1-carboxylic acid allyl ester 

Relevant academic research and scientific papers

Novel lβ-methylcarbapenems having cyclic sulfonamide moieties: Synthesis and evaluation of in vitro antibacterial activity

The synthesis of a new series of 1β-methylcarbapenems having cyclic sulfonamide moieties is described. Their in vitro antibacterial activities against both Gram-positive and Gram-negative bacteria were tested and the effect of substituent on the pyrrolidi

Synthesis and?biological evaluation of?1β-methylcarbapenems having cyclic thiourea moieties and?their?related compounds

The synthesis of a new series of 1β-methylcarbapenems having cyclic thiourea moieties is described. Their in vitro antibacterial activities against both Gram-positive and Gram-negative bacteria were tested and the effect of substituent on the pyrrolidine

Synthesis and Antibacterial Activity of 1β-Methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem Derivatives

Synthesis of a new series of 1β-methylcarbapenems with a substituted oxadiazolopyrrolidine moiety is described. Their in vitro antibacterial activities against both Gram-positive and Gram-negative bacteria were tested and the effect of the substituent on

Synthesis and antibacterial activity of 1β-methyl-2-[5-(N-substituted-2-hydroxy iminoethyl)pyrrolidin-3-ylthio]carbapenem derivatives

The synthesis of a new series of 1-methylcarbapenems having the substituted thiazolopyrrolidine moiety is described. Their in vitro antibacterial activities against both gram-positive and gram-negative bacteria were tested and the effect of substituent on

2-(substituted pyrrolidinylthio)carbapenem derivatives

A compound of the formula: STR1 wherein R is a hydrogen atom or a methyl group, R1 is a hydrogen atom or a negative charge, each of R2 and R3 which may be the same or different, is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a formimidoyl group, an acetoimidoyl group, --COOR4, --CON(R5)R6, --N(R5)R6, --CH2 COOR4, --CH2 N(R5)R6 or --CH2 CON(R5)R6 (wherein R4 is a hydrogen atom or a lower alkyl group, each of R5 and R6 which may be the same or different, is a hydrogen atom or a lower alkyl group, or R5 and R6 form together with the adjacent nitrogen atom a heterocyclic group selected from the group consisting of an aziridinyl group, an azetidinyl group, a pyrrolidinyl group and a piperidyl group), A is =NR7, =N+ (R7)R8, wherein each of R7 and R8 which may be the same or different, is a hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group, a formimidoyl group, an acetoimidoyl group, --COOR4, --CON(R5)R6, --N(R5)R6, --CH2 COOR4, --CH2 N(R5)R6 or --CH2 CON(R5)R6 (wherein R4, R5 and R6 are as defined above), p is an integer of from 0 to 3, and q is an integer of from 1 to 3; or a pharmaceutically acceptable salt or ester thereof.